ReclutandoNCT07241390
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Fase 3Eli Lilly and Company
Condiciones: Atherosclerosis Cardiovascular Disease, Chronic Kidney Disease
Sedes en Ciudad de México: RM Pharma Specialists - Unidad Especializada en Datos · Grupo Medico Camino Sc · Centro de Investigación Clinica Chapultepec
Ver registro oficial ↗ReclutandoNCT07355296
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Fase 2Boehringer Ingelheim
Condiciones: Proteinuric Kidney Diseases
Sedes en Ciudad de México: Health Pharma Professional Research S.A. de C.V. · Soltmed Smo · Inst Nac de Ciencias Medicas y Nutricion Salvador Zubiran
Ver registro oficial ↗ReclutandoNCT06307652
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Fase 3AstraZeneca
Condiciones: Heart Failure and Impaired Kidney Function
Sedes en Ciudad de México: Ver registro oficial
Ver registro oficial ↗ReclutandoNCT07227402
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Fase 3Merck Sharp & Dohme LLC
Condiciones: Renal Cell Carcinoma
Sedes en Ciudad de México: Higiea Oncologia ( Site 0504)
Ver registro oficial ↗ReclutandoNCT07624305
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Fase 3AstraZeneca
Condiciones: Renal Insufficiency, Chronic
Sedes en Ciudad de México: Ver registro oficial
Ver registro oficial ↗ReclutandoNCT07662135
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Fase 3AstraZeneca
Condiciones: Type 2 Diabetes Mellitus, Type 2 Diabetes With Chronic Kidney Disease
Sedes en Ciudad de México: Ver registro oficial
Ver registro oficial ↗ReclutandoNCT03619850
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
Fase 3AMAG Pharmaceuticals, Inc.
Condiciones: Chronic Kidney Disease; Iron Deficiency Anemia
Sedes en Ciudad de México: Instituto Nacional de Pediatria (INP) (National Institute of Pediatrics)
Ver registro oficial ↗ReclutandoNCT05485961
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Fase 2 / Fase 3CSL Behring
Condiciones: End Stage Kidney Disease
Sedes en Ciudad de México: Medica Santa Carmen
Ver registro oficial ↗ReclutandoNCT03549754
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
No indicadaAstraZeneca
Condiciones: Type 2 Diabetes, Hypertension, Chronic Kidney Disease
Sedes en Ciudad de México: Ver registro oficial
Ver registro oficial ↗ReclutandoNCT01524276
Product Surveillance Registry
No indicadaMedtronic
Condiciones: Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders
Sedes en Ciudad de México: Ver registro oficial
Ver registro oficial ↗